676560-66-0 Usage
General Description
2-Pyrrolidinecarbonitrile, 5-ethynyl-1-[[[2-(4-fluorophenyl)-1,1-dimethylethyl]amino]acetyl]-, (2S,5R)- is a chemical compound with potential biological and pharmacological significance. 2-Pyrrolidinecarbonitrile,
5-ethynyl-1-[[[2-(4-fluorophenyl)-1,1-dimethylethyl]amino]acetyl]-,
(2S,5R)- contains a pyrrolidine ring, an ethynyl moiety, and a fluorophenyl group, making it a complex and potentially versatile molecule. The stereochemistry of the compound is specified as (2S,5R), indicating the configuration of the chiral centers in the molecule. The presence of an acetyl group in the compound suggests potential interactions with enzymes or proteins in biological systems. The overall structure of this compound suggests that it may have activity as a pharmacological agent, possibly in the realm of neurological or psychiatric disorders. Further research and investigation into the properties and potential uses of this compound are warranted.
Check Digit Verification of cas no
The CAS Registry Mumber 676560-66-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,5,6 and 0 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 676560-66:
(8*6)+(7*7)+(6*6)+(5*5)+(4*6)+(3*0)+(2*6)+(1*6)=200
200 % 10 = 0
So 676560-66-0 is a valid CAS Registry Number.
676560-66-0Relevant articles and documents
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
-
, (2008/06/13)
The present invention relates to compounds that inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclero
PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV)
-
Page 87, (2010/11/30)
The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.
